secwatch.observer — SEC 8-K summary
======================================

Issuer:     Galera Therapeutics, Inc. (GRTX)
CIK:        0001563577
Form:       8-K
Filed at:   2023-09-26T23:59:59+00:00
Accession:  0001193125-23-241844
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Galera Therapeutics receives Nasdaq delisting notice for MVPHS non-compliance
-----------------------------------------------------------------------------

- Nasdaq notified Galera on Sep 25, 2023 that MVPHS fell below $15M required for Global Market listing.
- Company has 180 days, until March 25, 2024, to regain compliance by closing at $15M+ for 10 consecutive days.
- May consider transferring to Nasdaq Capital Market if compliance cannot be met on Global Market.
- Stock continues to trade under GRTX on Nasdaq Global Market; delisting risk if not cured by Compliance Date.
- No assurance that compliance will be regained or that an appeal would succeed if delisting proceeds.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563577/000119312523241844/0001193125-23-241844-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563577/000119312523241844/d514868d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-241844

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer